ACRS
Aclaris Therapeutics Inc
5.20$
-4.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | 0.00 | 0.00 | 0.06 | 0.31 | 0.10 | 0.15 | 0.12 | 0.46 | 0.45 | 0.24 | 0.06 | |
| – | 0.00 | 0.00 | 0.01 | 0.04 | 0.21 | 0.10 | 0.12 | 0.08 | 0.18 | 0.26 | 0.04 | 0.02 | |
| – | 0.00 | 0.00 | -0.01 | 0.02 | 0.10 | 0.00 | 0.03 | 0.04 | 0.27 | 0.19 | 0.21 | 0.05 | |
| 2.08 | 0.61 | 0.82 | 1.56 | 1.42 | 1.91 | 1.57 | 0.75 | 0.77 | 1.19 | 1.41 | 0.43 | 0.43 | |
| 1.06 | 0.19 | 0.29 | 0.70 | 1.18 | 0.84 | 0.66 | 0.48 | 0.42 | 0.39 | 0.45 | 0.29 | 0.18 | |
| 3.14 | 0.80 | 1.11 | 2.27 | 2.59 | 4.21 | 2.24 | 1.23 | 1.62 | 1.65 | 1.58 | 2.04 | 0.67 | |
| -3.14 | -0.80 | -1.11 | -2.27 | -2.58 | -4.11 | -2.69 | -1.20 | -1.58 | -1.38 | -1.39 | -1.84 | -0.62 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.41 | 0.07 | – | – | – | |
| -3.13 | -0.80 | -1.10 | -2.25 | -2.50 | -4.03 | -2.75 | -1.21 | -1.60 | -1.33 | -1.27 | -1.71 | -0.53 | |
| – | 0.00 | 0.00 | -0.01 | -0.07 | 0.08 | 0.71 | 0.00 | 0.41 | 0.03 | -0.01 | – | – | |
| -3.13 | -0.80 | -1.10 | -2.25 | -2.44 | -4.03 | -3.90 | -1.20 | -1.60 | -1.33 | -1.27 | -1.71 | -0.53 | |
| -3.13 | -0.80 | -1.11 | -2.26 | -2.56 | -4.06 | -2.18 | -1.17 | -1.14 | -1.29 | -1.65 | -0.67 | -0.53 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.